Dissertations / Theses on the topic 'Medical Advocacy'

Urban Bioethics
M.A.
The American medical profession has publicly pondered its roles and duties since its inception in the 18th century. Recently, that discussion has included whether or not advocacy by physicians is a responsibility of the profession. The following work is an argument and plan to support the ethical, professional imperative of physician advocacy. The historical underpinnings of the American medical profession suggest a responsibility to patients and interactions with society. In addition, there is a strong bioethical argument in favor of physician advocacy as an essential duty. Although there is a well-recognized set of barriers to physician advocacy, this article details solutions to help implement advocacy as a daily practice in the lives of all physicians. This piece will describe a way forward for physicians to take on their professional responsibility to advocate.
Temple University--Theses

Syftet med denna studie var att genom analys av tillgänglig litteratur inom området advocacy in nursing klarlägga innebörden av begreppet advocacy sett från sjukvårdens synpunkt, vem/vilka som skall ha funktionen som advocate i sjukvården, hur advocacy i praktiken bäst skall beskrivas inom sjukvården samt hur den som skall ha rollen som advocate bäst skall utbildas och föreberedas för sin uppgift. Som metod användes studium och analys av en selektion av tillgänglig litteratur inom området med speciell inriktning mot den egentliga innebörden av begreppet advocacy, argument för och emot sjuksköterskans funktion i rollen som advocate, hur advocacy bäst skall integreras och tillämpas i vårdprocessen och hur den som har rollen som advocate bäst skall förberedas för den. Resultat av litteraturstudien visade brist på enhetlig definition av begreppet advocacy, vilket skapar svårigheter att analysera och jämföra erfarenheter inom området. Även om motargument beskrevs, talade all erfarenhet inom området i denna studie för att sjuksköterskan är den mest lämpade att ha denna roll. Risken för att sjuksköterskan vid fullgörande av denna uppgift hamnar i en konfliktsituation mot övrig vårdpersonal betonades genomgående i denna litteratur, illustrerande betydelsen av att advocacy utförs som ett teamarbete med stöd och medverkan av all personal även om sjuksköterskan har huvudrollen. Behovet av utbildning för uppgiften framfördes genomgående, men inga konkreta förslag på utformning eller omfattning av sådan utbildning kunde identifieras. Konklusion: Begreppet advocacy in nursing är på väg att bli väl etablerat i vårdprocessen och sjuksköterskan har redan identifierats som den som bör ha denna roll. Fortsatt forskning inom området är angelägen för att ligga till grund både för metodik och utbildning inför uppgiften. Bättre och mer enhetlig definition av begreppet krävs för fortsatt vetenskapligt arbete.

Many survivors of sexual trauma describe the forensic rape exam as a second rape (Campbell et al., 1999; Parrot, 1991). Rape crisis medical advocates (RCMAs) assist survivors through this process, a time of particular vulnerability to retraumatization (Resnick, Acierno, Holmes, Kilpatrick, & Jager, 1999), by providing emotional support, education, and advocacy for comprehensive and respectful services. Campbell (2006) stated that the primary role of the RCMA is to reduce victim-blame, or the tendency to blame the victim of a crime for the crime or the circumstances leading up to it. The literature has consistently shown that survivors who worked with RCMAs received more medical and legal services and were less likely to feel revictimized (Campbell, 2006; Resnick et al., 1999; Wasco et al., 2004), but the impact of the work on RCMAs has not been sufficiently examined. Previous research has shown that many advocates experienced anger and fear in relation to the work (Wasco & Campbell, 2002), that RCMAs who witnessed more victim-blame reported less satisfaction with the work and lower levels of affective commitment to the job (Hellman & House, 2006), and that professional counselors who worked with trauma survivors reported higher levels of vicarious trauma than those who did not (Schauben & Frazier, 1995). Other researchers have shown that counselors who worked with trauma survivors reported higher traumatic stress than those who did not, and counselors who worked with victims of sexual trauma endorsed more disruptive beliefs about self, others, and the world (Bober & Regehr, 2005). However, the appropriateness of generalizing results observed among counselors to RCMAs is unclear. The purpose of this study was to examine possible predictors of RCMAs’ experiences of vicarious trauma (VT) and vicarious post-traumatic growth (VPTG). Since a great deal of research examining the effects of trauma on care-providers focuses on individual-level contributing variables like personality style, coping skills, and history of victimization (Kelley, Schwerin, Farrar, & Lane, 2005; King, King, Fairbank, & Adams, 1998; Pearlman & Mac Ian, 1995), in this study I examined the predictive ability of several environmental/contextual/systemic variables on RCMAs ratings of VT and VPTG, including caseload, amount of formal individual and group supervision received, ratings of social community at work, meaning of the work, emotional demands of the work, and perceptions of witnessing VB by police and medical staff. One hundred and sixty-four RCMAs participated in this internet-based survey research. A series of hierarchical regression analyses demonstrated that higher ratings of VT were predicted by younger age, lower amounts of formal group supervision received, and lower ratings of the social community at work and the meaning of the work. Ratings of VPTG were significantly and positively predicted by amount of formal individual supervision received, and negatively predicted by age and educational achievement. Interpretations and recommendations are provided to assist rape crisis agencies in supporting RCMAs in their work.

Thesis (D.C.P. / M. Sc.)--School of Psychology, Faculty of Science, University of Sydney, 2007.
Title from title screen (viewed on February 3, 2009) Degree awarded 2007; thesis submitted 2006. Submitted in fulfilment of the requirements for the degree of Doctor of Clinical Psychology/Master of Science to the School of Psychology, Faculty of Science. Includes bibliographical references. Also issued in print.

Urban Bioethics
M.A.
As a healthcare professional at the bedside, it has been very difficult to advocate for the patient while all parties involved cannot respect what the patient wants. Four out of five Americans do not have an advance directive. The history and court cases that have led the country to make patient’s right to make their own healthcare decisions has been decades in the making, yet still bring daily challenges within the healthcare system. When a patient’s wishes are not being honored, medical futility may lead to moral distress and compassion fatigue. Institutions provide multidisciplinary teams to address these issues, but if a patient’s capacity or competence is in question, their voice may not be heard. The toll on the healthcare provider and the patient can be permanently damaging, causing many nurses to leave the profession all together. I will attempt to determine the barriers to implementing the patient’s wishes, address the syndrome of moral distress among healthcare professionals, and attempt to offer solutions to promote well rounded, patient-centered care.
Temple University--Theses

The impetus for the recognition of the need for legal partners in healthcare came from Boston City Hospital in 1993. The hospital provided care to the largest uninsured and underinsured population in the New England states. The pediatric patients were noted by Dr. Barry Zuckerman to have difficulty in recovering from medical illnesses. He linked their inability to improve their health to poor housing, food insecurity, and basic social determinants of health. His hiring of a part-time lawyer led to a national movement for the development of medical-legal partnerships. The American Bar Association, the National Center for Medical-Legal Partnerships at George Washington University in Washington, DC and the American Academy of Pediatrics formed the first national medical-legal partnership in 2007. Joint resolutions were passed for members to become partners with the other professional colleagues to “address the legal and social issues affecting patient health and well-being.” The American Bar Association resolution led to the creation of the Medical-Legal Partnership Pro Bono Project. In 2015, the East Tennessee State University College of Nursing nurse-led community health center was awarded a small grant from the National Nurse Centers Consortium to participate in the development of a medical-legal partnership. The health center is staffed by Nurse Practitioners who provide health care for the underserved in northeast Tennessee. The patients are diverse and include homeless, migrants, residents of public housing, uninsured, and underinsured. Partnering with the Tennessee Justice Center in Nashville, Tennessee, the nurse-led medical legal partnership improved lives of pediatric patients, adults, pregnant women across the state, and advocacy rights for those who cannot speak for themselves.

This thesis considers the rationalization of health care in Canada. It focuses on the conflicting roles modern physicians play in our system, acting as both patient advocate and social agent. It begins by tracing the origin of both of these duties. It then examines the ethical, professional, and legal issues which arise in the limited circumstances where front-line physicians must participate in the rationing of health care. It offers a framework for resolving the double agent dilemma and states five interlocking recommendations which are the building blocks of the resolution.

In 2005, the House of Commons (HoC) Health Committee produced a report on The Influence of the Pharmaceutical Industry – the first of its kind since 1914. The inquiry concluded that there were ‘over-riding concerns about the volume, extent and intensity of the industry’s influence, not only on clinical medicine and research but also on patients, regulators, the media, civil servants and politicians’, and stressed the need ‘to examine critically the industry’s impact on health to guard against excessive and damaging dependencies’ (HoC 2005, p. 97). It also noted that it is important to comprehensively analyse pharmaceutical regulation in order to ascertain whether there are systemic problems: In some circumstances, one particular item of influence may be of relatively little importance. Only when it is viewed as part of a larger package of influences is the true effect of the company’s activity recognised and the potential for distortion seen. The possibility that certain components of any such campaign are covert and their source undeclared is particularly worrying. (HoC 2005, p. 97) This study addresses this recommendation and was primarily conducted to examine whether recognised concerns are merely ad hoc or as a result of systemic flaws in the current system of pharmaceutical regulation. The work addresses a gap in the academic literature by drawing on the fragmented criticisms of the pharmaceutical industry in order to produce a model to illustrate how various stakeholders collaborate with drug companies to promote licensed products, and to explore the nature of the relationships between these elite stakeholders. The thesis begins with a literature review which determines who is involved in pharmaceutical regulation; how the regulatory system works; and explores the key role of communication in this process (Chapters 1 to 3). The recurrent theme is the neglect or exclusion of the patient/consumer, which leads to the development a model of intra-elite communication in drug regulation called Pharmaffiliation (Chapter 3). The thesis then looks for evidence to support or refute this model, using multiple methods (Chapter 4). Four case studies (with specific selection criteria) are chosen to test the model’s constructs and indicators (Chapters 5 to 8). The research uncovers systemic problems in the current system of pharmaceutical regulation which can ultimately harm the patient/consumer, and the implications of these findings are discussed (Chapter 9). Solutions on a micro-level include consumer involvement in decision making processes, which can be enhanced through public education and awareness campaigns and the instigation of public inquiries whenever drugs are withdrawn from the market (HoC 2005, p. 105). On a macro-level, however, this will involve critically exploring neoliberal capitalism and the empowerment of the citizenry (Street 2001).

abstract: Advocacy groups work across many aspects of “death with dignity” practice and treatment, and provide insight across multiple aspects of “death with dignity”. This study argues that key advocacy groups in the American death with dignity movement influenced the broader conceptualization of death with dignity in a way that makes patients more able to achieve it. This influence has been a dynamic process across different periods of practice starting the discussion of “death with dignity” in 1985 through today, although this thesis extends only to 2011. The question in this study is how do the three main historical advocacy groups in the US: the Hemlock Society, Compassion in Dying, and Compassion and Choices, conceptualize death with dignity with regards to patient and doctor relationship, legal and policy factors, and medical technologies and protocols? This study found that the Hemlock Society (1980-2005) characterized death with dignity as a terminally ill patient being able to “self-deliver” from suffering via autoeuthanasia regardless of medical community approval or legality. Compassion in Dying (1993-2007) characterized death with dignity as involved advocacy work with terminal patients and their communities to pursue palliative care and hospice up to the point of assisted death. This organization was also involved in the passing of Oregon Death with Dignity Act. Compassion and Choices (2007-present) characterized death with dignity similarly to Compassion in Dying but also advocated for adequate management of pain and suffering symptoms in palliative care to prevent people from desiring death over the illness. Conceptualizing death with dignity is important for understanding why patients want death with dignity and better accommodating their end of life needs when they are suffering with terminal illness.
Dissertation/Thesis
Masters Thesis Biology 2019

Canada, like other countries around the world, has health inequities. The literature on social accountability and responsibility urges medical schools to be grounded in the needs of communities to address health inequities. The Canadian professional and regulatory bodies promote the CanMEDS Competencies of which one, the Health Advocate Competency, speaks of addressing community issues. Yet medical schools face challenges actualizing social responsibility and teaching the Health Advocate Competency. Therefore it is important to understand how the teaching of health advocacy and social responsibility is incorporated into the undergraduate curricula of self-defined socially responsible medical schools in Canada. In this study, mixed methods were used beginning with a semi-structured questionnaire administered to undergraduate Course Directors at two medical schools in Canada with a response rate of 74% (n=60). This was followed by a series of open-ended interviews with eleven equity leaders to bring their perspective into the data collection and establish knowledge about frontline intersectional equity work. The major theoretical lens encircling this work was intersectionality which examines historical oppression and how the intersection of gender, race, and class compound health inequities. Questionnaire results made it clear that biomedical ideology and the CanMEDS Medical Expert Competency were privileged in the undergraduate curriculum at the expense of other knowledge such as health advocacy and social responsibility. The objective biomedical discourse ignores or marginalizes important social influences on health which are highlighted by using an intersectional lens. The semi-structured interviews provided rich data about working in an intersectional equity framework highlighting the impact of the intersections of race, gender, class and other identities on health inequities. These interviews also demonstrate the importance of health advocacy in improving health care outcomes and addressing social responsibility. Incorporating intersectionality into previously accepted assessment tools for physicians adds an important dimension to the health care encounter. Explicitly embedding social responsibility and health advocacy in the medical school mission and curriculum is essential to their acceptance. A series of supporting recommendations are offered.

Policy is a rule to guide decisions and achieve rational outcomes while advocacy is a strategy to influence architects of decision making or policy makers when they make regulations and laws, distribute resources, and make other decisions that affect peoples' lives. The principal aims of policy advocacy as postulated by Kervatin in 1998 are to create policies, reform policies, and ensure policies are implemented. This study examines the role of civil society in policy advocacy, using the Treatment Action Campaign (TAC) as an example. Therefore, the study uses a content analysis method of data collection and analysis to explicate the various advocacy strategies employed by the Treatment Action Campaign to advocate for access to HIV/AIDs treatment in post-apartheid South Africa. The policy advocacy strategies of the TAC were investigated pertaining to the implementation of health policy on HIV/AIDS in South Africa. There are a variety of advocacy strategies employed by civil society organisations, such as discussing problems directly with policy makers, delivering messages through the media, or strengthening the ability of local organisations to advocate. These strategies are known as advocacy tools for planning successful advocacy initiatives. Most of them are clearly reflected in the case of the TAC organisation, which employed these strategies and others to advocate for HIV/AIDS policy change.
Thesis (M.Soc.Sc.)-University of KwaZulu-Natal, Pietermaritzburg, 2013.

It is important for nurses to show acceptable behaviour when interacting with the patients. The purpose of this study was to explore and describe the factors that contribute to nurses’ negative behaviour when rendering patient care and to determine the effects of nurses’ behaviour on patient outcomes. The study used a non-experimental explorative and descriptive quantitative design. Data collection was done using a structured questionnaire. The sample comprised of 64 respondents which consisted of 25 registered nurses and 39 enrolled nurses. The study found that besides the known contributing factor, that is, the shortage of nurses, further identified contributing factors to nurses’ negative behaviour when rendering patient care are failure to retrain nurses identified with negative behaviours, poor condition of employment and patients’ behaviours and cultural beliefs. These results suggested a need to train more nurses, improve conditions of employment, as well as support and retrain nurses identified with negative behaviours.
Health Studies
M.A. (Public Health)

Diploma thesis "Marihuana: drug or medicine?" deals with recent change of a medicine law and with process enabling treatment by marihuana. It identifies stakeholders and advocacy coalitions involved in the law and public policy enforcement and explains what is the motivation for these coalitions and on which values is the motivation based. Using event analysis this thesis shows timeline of events moving towards the change of the law and reveals the stakeholders who are significant for the change. Their public speeches are analyzed and stakeholders are divided into advocacy coalitions on the basis of the analysis. The conclusion of the qualitative content analysis is verified by half structured interviews with stakeholders representing the coalitions. Three coalitions were identified in cannabis subsystem. First of them is liberal and tries to get the legalization trough, the second one tries to enable a treatment by marihuana for patients and the third coalition is skeptic to cannabis treatment. The thesis explains a participation of these coalitions on the change and their relations to each other.

La présente thèse, organisée en trois volets, poursuivait trois objectifs : i) Estimer les coûts médicaux directs du traitement du DT2 dans 4 pays d’Afrique subsaharienne et dans le cas du Mali, rapprocher ces coûts médicaux directs estimés aux dépenses effectives des patients diabétiques ; ii) Examiner le coût-efficacité des interventions de prévention basées sur la modification du mode de vie chez les sujets à haut risque du DT2; iii) Cerner la perception et les attitudes des acteurs de la santé sur les outils de plaidoyer développés dans le cadre du projet DFN et leur potentiel d’impact sur les décideurs. Dans le premier volet, il s’est agi d’estimer les coûts du DT2 et de ses complications au moyen d’un calculateur et de le mettre à l’épreuve au Bénin, au Burkina- Faso, en Guinée et au Mali. Les composantes de soins pour le DT2 et ses complications avaient été définies au préalable par une équipe de spécialistes, sur la base de leur expérience clinique et des lignes directrices existantes. Les prix ont été relevés dans deux structures hospitalières du secteur public et deux du privé. Les coûts ont été estimés sur une base annuelle pour le DT2 avec ou sans complications chroniques puis par épisode pour les complications aiguës. Dans le cas du Mali, ces coûts ont été rapprochés des dépenses de patients diabétiques d’après une précédente enquête transversale dans ce pays. Cette enquête portait sur 500 sujets diabétiques sélectionnés au hasard dans les registres. Les dépenses pour les soins des trois derniers mois avaient été relevées. Les déterminants des dépenses ont été explorés. Il ressort des différences de coûts dans le même secteur puis entre le secteur privé et le secteur public. Le coût minimum du traitement du DT2 sans complications dans le secteur public représentait entre 21% et 34% de PIB par habitant, puis entre 26% - 47% en présence de la rétinopathie et au-delà de 70% pour la néphropathie, la complication chronique la plus coûteuse. Les dépenses des sujets diabétiques enquêtés au Mali, étaient en deçà des coûts minima estimatifs des différentes complications excepté la rétinopathie et le DT2 sans complication. Les facteurs comme l’insulinothérapie, le nombre de complications et la résidence dans la capitale étaient significativement associés aux dépenses plus élevées des patients. Dans le second volet, la revue systématique a consisté à recenser les études d’évaluation économique des interventions de prévention du DT2 dans des groupes à haut risque par l’alimentation et/ou l’activité physique. Les interventions de contrôle de l’obésité comme facteur de risque majeur de DT2 ont également été considérées. Les études ont été sélectionnées dans les bases de données scientifiques en utilisant les mots clés et des critères prédéfinis. Les études originales publiées entre janvier 2009 et décembre 2014 et conduites en français, anglais ou espagnol étaient potentiellement éligibles. La liste de contrôle de « British Medical Journal » a servi à évaluer la qualité des études. Des 21 études retenues, 15 rapportaient que les interventions étaient coût-efficaces suivant les limites d’acceptabilité considérées. Six études étaient non concluantes, dont quatre destinées à la prévention du DT2 et deux, au contrôle de l’obésité. Dans le troisième volet, les perceptions d’utilisateurs potentiels de ce calculateur et d’un autre outil de plaidoyer, à savoir, l’argumentaire narratif expliquant la nécessité de se pencher sur la lutte contre le DT2 en Afrique, ont été évaluées dans une étude qualitative exploratoire. Les données ont été collectées au cours d’entretiens individuels avec 16 acteurs de la santé de quatre pays d’Afrique subsaharienne et un groupe de discussion avec 10 étudiants de master de nutrition à l’issue d’un atelier de formation sur le plaidoyer faisant appel à ces outils, au Bénin. Les entretiens ont été enregistrés, transcrits et codés à l’aide du logiciel QDA Miner. Les participants ont souligné la pertinence des outils pour le plaidoyer et la convivialité du calculateur de coûts. Il demeure cependant que le contexte politique marqué par la compétition des priorités, l’absence de cohésion entre les décideurs et un défaut de données notamment sur le coût-efficacité des interventions sont des freins à la priorisation du DT2 dans les politiques de santé en Afrique subsaharienne que les répondants ont relevés. L’étude confirme que le traitement du DT2 est financièrement inabordable pour un grand nombre de patients. Elle souligne que les dépenses des patients sont en deçà des coûts estimés pour un traitement approprié avec quelques exceptions. La prévention du DT2 basée le mode de vie est coût-efficace mais devrait être étudiée en Afrique. On peut espérer que la pertinence des outils de ce travail telle que relevée par les acteurs de santé se traduise par leur utilisation. Ceci pour susciter des interventions de prévention afin d’infléchir l’évolution du DT2 et son impact économique en Afrique subsaharienne.
This thesis is organized in three different parts with three objectives: i) To estimate the direct medical costs of treatment of T2D in four sub-Saharan African countries and in the case of Mali, compare the direct medical costs estimated from prices used in the health system to the real expenditures of diabetic patients, ii) To evaluate the perceptions of health professionals on advocacy tools for T2D including the cost calculator used to estimate medical costs and a narrative argument developed under the Double Burden Nutritional project, iii) To examine the cost effectiveness of economic evaluation of lifestyle interventions for primary prevention of T2D. In the first part of the study, we estimated the costs of T2D and its complications in Benin, Burkina - Faso, Guinea and Mali. The care components for T2D and its complications were defined by a team of specialists, based on their clinical experience and current guidelines. Prices were collected from two public healthcare facilities and two private facilities. The costs were estimated on an annual basis for T2D with or without chronic complications and per episode for acute complications. The estimated annual costs in Mali were compared to diabetic patients’ expenditures based on data from a cross-sectional survey conducted earlier in that country. The survey covered 500 diabetic subjects randomly selected from the registry of known diabetics. Data on expenditures for care in the last three months were collected. Determinants of expenditures were examined. The results showed cost disparities within countries, within and between the private and the public sector. The minimum cost of treatment of T2D without complications in the public sector amounted to 21% - 34% of the country’s Gross National Income per capita; 26% - 47% in the presence of retinopathy - the cheapest complication -, and above 70 % for nephropathy, the most costly complication. According to Mali survey, diabetic subjects’ expenditures were below the estimated minimum cost, except for diabetes without complications or only with retinopathy. Insulin therapy, the number of complications and residing in the capital were significantly associated with higher expenditures. The second part of the thesis consists of the systematic review of economic evaluation studies of T2D prevention interventions in high-risk groups through diet and physical activity. Interventions to control obesity as a major risk factor for T2D were also considered. The studies were extracted from scientific databases using keywords and predefined criteria. Original studies published between January 2009 and December 2014 and conducted in French, English or Spanish were potentially eligible. The "British Medical Journal" checklist was used to assess the quality of studies. Of the 21 studies included, 15 reported that the interventions were cost-effective as per the acceptability limits considered. Six studies were inconclusive, including four for T2D prevention and two for obesity control. In the third second part, the perceptions of potential users of the cost calculator and another advocacy tool, namely, the narrative set of arguments explaining the need to address T2D in Africa, were evaluated in an exploratory qualitative study. Data were collected through individual interviews of 16 health professionals from four sub-Saharan countries and a focus group with 10 Master’s students in nutrition during a training workshop on advocacy using these tools, in Benin. The questions pertained to the two tools and to factors involved in the prioritization of health policy, with a focus on T2D. Interviews were recorded, transcribed and coded using the QDA Miner software. Participants underlined the relevance of the tools for advocacy. They considered the cost calculator as user – friendly. It remains that the political context characterized by competing priorities, lack of cohesion between policy makers, and lack of data, especially the cost - effectiveness of interventions, are challenges for positioning T2D as a priority in public policies in sub-Saharan African countries. The studies confirmed that treatment of T2D is unaffordable for many patients. It highlighted the fact that expenses of patients were below the estimated costs for minimal treatment with some exceptions. Prevention of T2D based on lifestyle modification appears cost-effective but studies should be conducted in Africa. We hope that the tools, which were found relevant by health actors of the four countries, will be helpful in stimulating preventive interventions in order to reduce the trend of T2D and its economic burden in sub-Saharan Africa.

Thesis (M.A.)--University of Alberta, 2010.
Title from PDF file main screen (viewed on July 14, 2010). "A thesis submitted to the Faculty of Graduate Studies and Research in partial fulfillment of the requirements for the degree of Master of Arts, Department of Music ... Fall 2010, Edmonton, Alberta". Includes in Appendix A, poetry and song lyrics. Includes bibliographical references and index of song titles, lyrics or themes.

À la suite du dévoilement d’une agression sexuelle, l’examen médical est l’une des étapes importantes qui sont recommandées pour les enfants victimes, mais seulement certains d’entre eux le complètent. L’objectif de la présente étude est de vérifier si les enfants qui font l’examen anogénital à la suite du dévoilement d’agression sexuelle sont différents de ceux qui n’en font pas ainsi que de documenter les variables, notamment les caractéristiques de l’enfant, de la famille, de l’agresseur et de l’agression, qui pourraient prédire le fait de compléter cet examen. L’échantillon est composé de 211 enfants âgés de 6 à 13 ans recevant des services au Centre d’expertise Marie-Vincent. Une régression logistique binaire révèle que l’absence d’emploi de la mère (RC = 6,15), être victime d’une agression sexuelle très sévère (RC = 6,02), être victime d’un agresseur adulte (RC = 3,43) et provenir d’une famille monoparentale (RC = 2,89) contribuent à prédire si l’examen anogénital est réalisé ou pas à la suite du dévoilement. Les résultats confirment que les enfants complètent l’examen surtout afin de trouver des éléments de preuves et que parmi ceux qui pourraient en bénéficier pour leur bien-être, plusieurs ne sont pas rencontrés.
Following the disclosure of sexual assault, the medical examination is one of the most important steps recommended for child victims, but only some of them undergo the examination. The objective of this study was to determine whether children who undergo an anogenital examination following a disclosure of sexual assault are different than those who do not, as well as to document the variables, particularly, the characteristics of the child, the family, the aggressor and the assault, that could predict whether or not an anogenital examination is conducted. The study group was composed of 211 children within between the ages of 6 to 13 years old receiving services at the Centre d’expertise Marie-Vincent. A binary logistic regression reveals that when the mother is unemployed (RC = 6.15), being a victim of a very violent sexual assault (RC = 6.02), being a victim of an adult aggressor (RC = 3.43) and coming from a single-parent family (RC = 2.89) contribute to predicting if the anogenital exam is given or not following the disclosure. Results confirm that the primary goal of the anogenital examination is to find elements of proof and that many children who could benefit from this test for their wellbeing are not being examined.

This study disaggregates and evaluates conventional community psychology as reflected in both the Community Mental Health and Social Action Models. In so doing, it provides evidence in support of its plea for a radical paradigm shift towards ecosystemic theorising in the field of community psycho logy. It further illustrates that an ecosystemic point of departure would have significant implications for the reformulation of conventional notions of community. It concludes by teasing out some alternative praxis related community psychological formulations.
Psychology
M.A. (Clinical Psychology)

Indiana University-Purdue University Indianapolis (IUPUI)
Oral health is crucial to overall health and a focus of the U.S. Health Center program, which provides preventive dental services in medically underserved communities. Dental hygiene is an oral health profession whose practice is focused on dental disease prevention and oral health promotion. Variations in the practice and regulation of dental hygiene has been demonstrated to influence access to dental care at a state level; restrictive policies are associated lower rates of access to care. Understanding whether and to what extent policy variations affect availability and access to dental care and the oral health of medically underserved communities served by grantees of the U.S. Health Center program is the focus of this study. This longitudinal study examines dental service utilization at 1,135 health center grantees that received community health center funding from 2004 to 2011. The Dental Hygiene Professional Practice Index (DHPPI) was used as an indicator of the state policy environment. The influence of grantee and state level characteristics are also considered. Mixed effects models were used to account for correlations introduced by the multiple hierarchical structure of the data. Key findings of this study demonstrate that state policy environment is a predictor of the availability and access to dental care and the oral health status of medically underserved communities that received care at a grantee of the U.S. Health Center program. Grantees located in states with highly restrictive policy environments were 73% less likely to deliver dental services and, those that do, provided care to 7% fewer patients than those grantees located in states with the most supportive policy environments. Population’s served by grantees from the most restrictive states received less preventive care and had greater restorative and emergency dental care needs. State policy environment is a predictor of availability and access to dental care and the oral health status of medically underserved communities. This study has important implications for policy at the federal, state, and local levels. Findings demonstrate the need for policy and advocacy efforts at all levels, especially within states with restrictive policy environments.